Chemoinformaics analysis of 2,5-bis(1,1-dimethyletyl)
| Molecular Weight | 206.329 | nRot | 0 |
| Heavy Atom Molecular Weight | 184.153 | nRig | 6 |
| Exact Molecular Weight | 206.167 | nRing | 1 |
| Solubility: LogS | -4.664 | nHRing | 0 |
| Solubility: LogP | 4.916 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 38.8514 |
| nHD | 1 | BPOL | 22.0706 |
| QED | 0.68 |
| Synth | 2.173 |
| Natural Product Likeliness | 0.007 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.612 |
| Pgp-sub | 0.007 |
| HIA | 0.717 |
| CACO-2 | -5.041 |
| MDCK | 0.0000109 |
| BBB | 0.314 |
| PPB | 0.98429 |
| VDSS | 4.735 |
| FU | 0.0483543 |
| CYP1A2-inh | 0.937 |
| CYP1A2-sub | 0.931 |
| CYP2c19-inh | 0.787 |
| CYP2c19-sub | 0.766 |
| CYP2c9-inh | 0.685 |
| CYP2c9-sub | 0.877 |
| CYP2d6-inh | 0.887 |
| CYP2d6-sub | 0.862 |
| CYP3a4-inh | 0.484 |
| CYP3a4-sub | 0.67 |
| CL | 6.094 |
| T12 | 0.265 |
| hERG | 0.015 |
| Ames | 0.009 |
| ROA | 0.123 |
| SkinSen | 0.699 |
| Carcinogencity | 0.033 |
| EI | 0.986 |
| Respiratory | 0.708 |
| NR-Aromatase | 0.027 |
| Antiviral | Yes |
| Prediction | 0.777731 |